IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples